Unknown

Dataset Information

0

HESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury.


ABSTRACT: Human pluripotent stem cells (hPSCs) have been differentiated to astroglia, but the utilization of hPSC-derived astroglia as cell therapy for neurological diseases has not been well studied. Astroglia are heterogeneous, and not all astroglia are equivalent in promoting neural repair. A prerequisite for cell therapy is to derive defined cell populations with superior therapeutic effects. Here we use an Olig2-GFP human embryonic stem cell (hESC) reporter to demonstrate that hESC-derived Olig2(+) progenitors generate a subtype of previously uncharacterized astroglia (Olig2PC-Astros). These Olig2PC-Astros differ substantially from astroglia differentiated from Olig2-negative hESC-derived neural progenitor cells (NPC-Astros), particularly in their neuroprotective properties. When grafted into brains subjected to global ischaemia, Olig2PC-Astros exhibit superior neuroprotective effects and improved behavioural outcome compared to NPC-Astros. Thus, this new paradigm of human astroglial differentiation is useful for studying the heterogeneity of human astroglia, and the unique Olig2PC-Astros may constitute a new cell therapy for treating cerebral ischaemia and other neurological diseases.

SUBMITTER: Jiang P 

PROVIDER: S-EPMC3903179 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

hESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury.

Jiang Peng P   Chen Chen C   Wang Ruimin R   Chechneva Olga V OV   Chung Seung-Hyuk SH   Rao Mahendra S MS   Pleasure David E DE   Liu Ying Y   Zhang Quanguang Q   Deng Wenbin W  

Nature communications 20130101


Human pluripotent stem cells (hPSCs) have been differentiated to astroglia, but the utilization of hPSC-derived astroglia as cell therapy for neurological diseases has not been well studied. Astroglia are heterogeneous, and not all astroglia are equivalent in promoting neural repair. A prerequisite for cell therapy is to derive defined cell populations with superior therapeutic effects. Here we use an Olig2-GFP human embryonic stem cell (hESC) reporter to demonstrate that hESC-derived Olig2(+) p  ...[more]

Similar Datasets

| S-EPMC4920671 | biostudies-literature
| S-EPMC6294286 | biostudies-literature
| S-EPMC7319181 | biostudies-literature
| S-EPMC3065213 | biostudies-literature
| S-EPMC7695963 | biostudies-literature
| S-EPMC10247757 | biostudies-literature
| S-EPMC3335315 | biostudies-literature
| S-EPMC1345718 | biostudies-literature
2015-08-07 | GSE61947 | GEO
| S-EPMC2872647 | biostudies-literature